Stability Indicating RP-HPLC Method for the Estimation of Impurities in Esomeprazole Gastro-Resistant Tablets by AQbD Approach
BIO Integration · 2024 · 5 (1)
DOI: 10.15212/bioi-2024-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIO Integration, 2024. Verfasst von Vikram Gharge und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Esomeprazole (ESO) gastro-resistant tablets (40 mg) are sold under the brand name, Zosa, which effectively manages conditions associated with the overproduction of gastric acid, including peptic ulcer disease and Zollinger-Ellison syndrome. The present study quantifies impurities in esomeprazole using advanced analytical techniques known as analytical quality by design with high-performance liquid chromatography.
Methods
Buffer selection (pH 7.6) and mobile phase composition (75:25 v/v) were optimized utilizing a YMC C18 column (150 mm × 4.6 mm; particle size, 3 μm) with a flow rate of 1.0 mL/min. The analyte was monitored with a UV/PDA detector at a wavelength of 280 nm. The stability-indicating nature of the method was confirmed based on forced degradation studies. The method validation was performed per ICH guidelines. Linearity, specificity, limit of detection, limit of quantification, precision, accuracy, solution stability, and robustness parameters were validated.
Results
All validation parameters were within an acceptable range. Excellent linearity with correlation coefficient values > 0.99 was achieved across the quantification limit. The solution stability study demonstrated no significant increase in percent impurity over a 24-h period. Analytical quality by design was instrumental in defining the design range for buffer pH and mobile phase composition, ensuring robust method performance. It was confirmed that 75% buffer solution, 25% acetonitrile, and pH 7.6 were the ideal conditions for determination of ESO impurities.
Conclusion
The validated method provides a reliable tool for accurately quantifying impurities in ESO tablet formulations.
Zitieren
APA
Gharge, V., Gadhe, A., Mohite, V., Jadhav, B., Dighe, V., Bhange, S., & Kakade, S. (2024). Stability Indicating RP-HPLC Method for the Estimation of Impurities in Esomeprazole Gastro-Resistant Tablets by AQbD Approach. BIO Integration, 5(1). https://doi.org/10.15212/bioi-2024-0018
Vancouver
Gharge V, Gadhe A, Mohite V, Jadhav B, Dighe V, Bhange S, et al. Stability Indicating RP-HPLC Method for the Estimation of Impurities in Esomeprazole Gastro-Resistant Tablets by AQbD Approach. BIO Integration. 2024;5(1). doi:10.15212/bioi-2024-0018
BibTeX
@article{Gharge2024,
author = {Gharge, Vikram and Gadhe, Anil and Mohite, Vikas and Jadhav, Balasaheb and Dighe, Vitthal and Bhange, Shubham and Kakade, Sushma},
title = {Stability Indicating RP-HPLC Method for the Estimation of Impurities in Esomeprazole Gastro-Resistant Tablets by AQbD Approach},
journal = {BIO Integration},
year = {2024},
volume = {5},
number = {1},
doi = {10.15212/bioi-2024-0018}
}
EUVIMED